TradeFlare's AI research teams analysed VOR on 7 market nights between July 3, 2026 and September 18, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 18, 2026 | HOLD | $21.89 | — / — | -13.5% | not yet | The current setup does not warrant a buy, and the market regime is neutral, suggesting caution. |
| September 8, 2026 | HOLD | $25.05 | — / — | -11.1% | -27.1% | The current market and stock-specific signals do not warrant a buy. |
| September 7, 2026 | HOLD | $25.05 | — / — | -11.1% | -27.1% | The current market regime and VOR's specific situation do not warrant a buy at this time. |
| July 8, 2026 | BUY | $20.10 | — / — | -11.0% | +9.7% | Positive clinical trial data for telitacicept. |
| July 7, 2026 | BUY | $20.59 | — / — | -8.0% | +10.7% | The PEAD signal is short-term in nature, and the underlying fundamentals and risk profile do not support a longer-term holding. |
| July 6, 2026 | BUY | $20.59 | — / — | -10.3% | +6.5% | The PEAD signal is short-term in nature, and the underlying fundamentals and risk profile do not support a longer-term holding. |
| July 3, 2026 | BUY | $20.59 | — / — | -10.3% | +6.5% | Post-earnings drift signal from scanner. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.